Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
Clinical trial NCT00964158 · COMPLETED
Trial details
- NCT number
- NCT00964158
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-10
- Primary completion
- 2010-11-27
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.